BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28320396)

  • 1. Occurrence of bla
    Ingti B; Paul D; Maurya AP; Bora D; Chanda DD; Chakravarty A; Bhattacharjee A
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):13. PubMed ID: 28320396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
    Shaheen BW; Nayak R; Foley SL; Kweon O; Deck J; Park M; Rafii F; Boothe DM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Response of Multiple ESBL Genes Within Escherichia coli Under Oxyimino-Cephalosporin Stress.
    Maurya AP; Chanda DD; Bora D; Das Talukdar A; Chakravarty A; Bhattacharjee A
    Microb Drug Resist; 2017 Mar; 23(2):133-138. PubMed ID: 27214038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferable DHA-1 cephalosporinase in Escherichia coli.
    Giakkoupi P; Tambic-Andrasevic A; Vourli S; Skrlin J; Sestan-Crnek S; Tzouvelekis LS; Vatopoulos AC
    Int J Antimicrob Agents; 2006 Jan; 27(1):77-80. PubMed ID: 16352422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of β-lactamase and 16S rRNA methylase genes among clinical Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from animals.
    Liu BT; Liao XP; Yue L; Chen XY; Li L; Yang SS; Sun J; Zhang S; Liao SD; Liu YH
    Microb Drug Resist; 2013 Jun; 19(3):237-45. PubMed ID: 23289437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
    Réjiba S; Mercuri PS; Power P; Kechrid A
    Microb Drug Resist; 2011 Jun; 17(2):135-40. PubMed ID: 21288137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.
    Taneja N; Mewara A; Kumar A; Verma G; Sharma M
    J Antimicrob Chemother; 2012 Jun; 67(6):1347-53. PubMed ID: 22410619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.
    Alyamani EJ; Khiyami AM; Booq RY; Majrashi MA; Bahwerth FS; Rechkina E
    Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):1. PubMed ID: 28061852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.